Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new look at erythromycin.

R W Lacey

    Postgraduate Medical Journal
    |April 1, 1977
    PubMed
    Summary

    Erythromycin is an underused antibiotic due to exaggerated resistance fears and toxicity concerns. This review highlights its efficacy in various infections, advocating for its reconsidered use in antibiotic therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts.

    The Journal of antimicrobial chemotherapy·1996
    Same author

    Cheese and Salmonella infection. Distribution and retail of cheese, not just production, may lead to contamination.

    BMJ (Clinical research ed.)·1996
    Same author

    Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Bovine spongiform encephalopathy is being maintained by vertical and horizontal transmission.

    BMJ (Clinical research ed.)·1996
    Same author

    The rheumato-microbiological interface.

    British journal of rheumatology·1995
    Same author

    Stability of amoxycillin and potassium clavulanate in co-amoxiclav oral suspension.

    Journal of clinical pharmacy and therapeutics·1994
    Same author

    Vertical transfer of prion disease.

    Human reproduction (Oxford, England)·1994

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Microbiology

    Background:

    • Erythromycin is a macrolide antibiotic with a long history of use.
    • Concerns regarding bacterial resistance and drug toxicity have influenced its clinical application.
    • The development of newer antibiotics has led to a perceived decline in erythromycin's utility.

    Purpose of the Study:

    • To review the current role of erythromycin in contemporary antibiotic treatment strategies.
    • To address common misconceptions regarding erythromycin's resistance patterns and safety profile.
    • To identify key clinical indications where erythromycin remains a valuable therapeutic option.

    Main Methods:

    • Literature review of existing studies and clinical guidelines on erythromycin.
    • Analysis of data concerning erythromycin resistance trends.
    • Evaluation of the safety and efficacy data for erythromycin and its derivatives.
    • Comparison of erythromycin's effectiveness against newer antibiotic agents.

    Main Results:

    • The fear of erythromycin resistance has been largely overstated.
    • Significant toxicity is primarily linked to a specific derivative, erythromycin estolate.
    • Newer antibiotics have rarely shown clear superiority over erythromycin in clinical outcomes.
    • Erythromycin remains effective for respiratory tract infections, otitis media, sinusitis, skin and soft tissue infections, osteomyelitis, prostatitis, and infections caused by Mycoplasma, Chlamydia, and anaerobes.

    Conclusions:

    • Erythromycin is currently underutilized in clinical practice.
    • Its established efficacy and generally favorable safety profile (excluding the estolate) support its broader application.
    • Erythromycin should be reconsidered as a primary treatment option for a range of common bacterial infections.

    Related Experiment Videos